We are live on ! Find out more

1,038 hedge funds and large institutions have $35.8B invested in MetLife in 2019 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 339 increasing their positions, 423 reducing their positions, and 96 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more funds holding in top 10

Funds holding in top 10: 1320 (+7)

15% more capital invested

Capital invested by funds: $31.2B → $35.8B (+$4.61B)

0.67% less ownership

Funds ownership: 76.62%75.94% (-0.67%)

1% less first-time investments, than exits

New positions opened: 95 | Existing positions closed: 96

2% less funds holding

Funds holding: 1,0541,038 (-16)

15% less call options, than puts

Call options by funds: $470M | Put options by funds: $551M

20% less repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 423

Holders
1,038
Holders Change
-16
Holders Change %
-1.52%
% of All Funds
22.44%
Holding in Top 10
20
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+53.85%
% of All Funds
0.43%
New
95
Increased
339
Reduced
423
Closed
96
Calls
$470M
Puts
$551M
Net Calls
-$80.4M
Net Calls Change
-$72.7M

MET Hedge Fund Activity: Q2 2019 in Review

1,038 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in MetLife (MET) for Q2 2019, worth a combined $35.8B — up 15% from $31.2B a quarter earlier.

Sellers outnumbered buyers: 96 funds closed out of MET and 95 opened new positions — a net loss of 1 holder — while 423 trimmed existing stakes and 339 added.

The largest buyer was Nuveen, adding an estimated $231M. The largest seller was Fidelity Investments, cutting an estimated $210M.

  • 1,038 institutional investors held MetLife (MET) as of Q2 2019, down from 1,054 in Q1 2019.
  • Funds reported $35.8B of MetLife stock for Q2 2019, up 15% quarter-over-quarter.
  • 95 funds opened new MetLife positions in Q2 2019 and 96 closed out, a net change of -1 holder.
  • The largest MetLife buyer in Q2 2019 was Nuveen, an estimated $231M added.
  • The largest MetLife seller in Q2 2019 was Fidelity Investments, an estimated $210M sold.

Based on aggregated 13F filings for Q2 2019.